Breaking News Instant updates and real-time market news.

CTAS

Cintas

$112.60

1.24 (1.11%)

, GK

G&K Services

$95.49

-0.43 (-0.45%)

08:25
10/03/16
10/03
08:25
10/03/16
08:25

Cintas price target raised to $135 on G&K Services synergies at KeyBanc

KeyBanc analyst Joe Box raised his price target on Cintas (CTAS) to $135 from $130 as his analysis leads him to think the $130M-$140M synergy target related to the company's G&K Services (GK) deal may be conservative. While the FTC did issue a "second request" on the deal, Box continues to believe there is a high likelihood that the deal closes.

CTAS

Cintas

$112.60

1.24 (1.11%)

GK

G&K Services

$95.49

-0.43 (-0.45%)

CTAS Cintas
$112.60

1.24 (1.11%)

08/18/16
08/18/16
NO CHANGE

Cintas acquisition positive, says RBC Capital
After Cintas agreed to buy competitor G&K Services, RBC Capital analyst Gary Bisbee says that G&K is "a good strategic fit" for Cintas. Bisbee says that the deal will increase Cintas' growth potential and "should be as much as 20% accretive over the next several years." He raised his price target on the shares to $113 from $94 and keeps a Sector Perform rating on the stock.
08/19/16
OPCO
08/19/16
NO CHANGE
OPCO
Perform
Oppenheimer sees Cintas acquisition of G&K Services as positive
Oppenheimer analyst Scott Schneeberger views the "opportunistic" acquisition of G&K Services by Cintas favorably, and anticipates a "smooth" multiyear integration. The analyst expects the acquisition to provide sourcing efficiencies, access to additional processing capacity, increased route density, corporate overhead efficiencies and potential cross selling opportunities. The analyst reiterates a Perform rating on Cintas' shares, with an "incrementally favorable perspective."
08/25/16
MACQ
08/25/16
INITIATION
Target $130
MACQ
Neutral
Cintas initiated with a Neutral at Macquarie
Macquarie analyst Hamzah Mazari initiated Cintas with a Neutral and $130 price target.
09/29/16
MSCO
09/29/16
NO CHANGE
Target $87
MSCO
Underweight
Cintas valuation appears full, says Morgan Stanley
Morgan Stanley analyst Toni Kaplan views Cintas (CTAS) valuation as full and expects shares to be pressured as organic growth slows from from a deceleration in uniform employment and waning exuberance for the G&K Services acquisition. Kaplan believes Cintas' cross selling opportunities may have reached a peak and believes the company has largely exhausted geographical expansion. The analyst rates Cintas an Underweight with an $87 price target on shares.
GK G&K Services
$95.49

-0.43 (-0.45%)

08/17/16
LEHM
08/17/16
UPGRADE
Target $130
LEHM
Overweight
Cintas upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Manav Patnaik upgraded Cintas (CTAS) to Overweight saying the company has made the deal he's being waiting for with its acquisition of G&K Services (GK). He believes the deal makes "a lot of sense" and upped his price target for Cintas shares to $130 from $110.
08/17/16
BARD
08/17/16
UPGRADE
Target $140
BARD
Outperform
Cintas upgraded to Outperform at Baird
As reported previously, Baird analyst Andrew Wittman upgraded Cintas (CTAS) to Outperform from Neutral. The analyst cited the company's buyout of G & K Services (GK) and its cost synergy opportunities along with the opportunity to extend its leading growth profile. Wittman sees multiple levers to drive value for several years and reiterated his Outperform rating on Cintas shares.
08/18/16
JPMS
08/18/16
DOWNGRADE
Target $97
JPMS
Neutral
G&K Services downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Andrew Steinerman downgraded G&K Services (GK) to Neutral citing the takeover by Cintas (CTAS). The analyst views the deal as positive for both companies and feels the offer price is a "healthy value."

TODAY'S FREE FLY STORIES

HEES

H&E Equipment

$26.97

-0.2 (-0.74%)

07:04
09/26/17
09/26
07:04
09/26/17
07:04
Initiation
H&E Equipment initiated  »

H&E Equipment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOG

Northern Oil and Gas

$0.94

0.093 (10.98%)

07:04
09/26/17
09/26
07:04
09/26/17
07:04
Hot Stocks
Northern Oil and Gas announces settlement with former CEO »

Northern Oil and Gas…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$83.14

0.26 (0.31%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Hot Stocks
Breaking Hot Stocks news story on Darden »

Darden reports Q1 Olive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BTX

BioTime

$2.72

-0.08 (-2.86%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Hot Stocks
BioTime announces 'positive' secondary, long-term data from Renevia trial »

BioTime announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

MBRX

Moleculin Biotech

$2.41

-0.07 (-2.82%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Hot Stocks
Moleculin Biotech announces FDA approval of Annamycin IND »

Moleculin Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNCA

Genocea

$5.33

0.04 (0.76%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Downgrade
Genocea rating change  »

Genocea downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

DRI

Darden

$83.14

0.26 (0.31%)

07:03
09/26/17
09/26
07:03
09/26/17
07:03
Hot Stocks
Darden reports Q1 blended same-restaurant sales from legacy brands up 1.7% »

Q1 same-restaurant sales…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AKBA

Akebia

$17.90

0.33 (1.88%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Hot Stocks
Breaking Hot Stocks news story on Akebia »

Akebia: Phase 2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AXON

Axovant Sciences

$24.25

-0.74 (-2.96%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Hot Stocks
Breaking Hot Stocks news story on Axovant Sciences »

Axovant announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRI

Darden

$83.14

0.26 (0.31%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Earnings
Darden backs FY18 adjusted cont ops EPS view $4.38-$4.50, consensus $4.47 »

The company reaffirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AKBA

Akebia

$17.90

0.33 (1.88%)

07:02
09/26/17
09/26
07:02
09/26/17
07:02
Hot Stocks
Breaking Hot Stocks news story on Akebia »

Akebia: Phase 3…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

AKBA

Akebia

$17.90

0.33 (1.88%)

07:01
09/26/17
09/26
07:01
09/26/17
07:01
Hot Stocks
Akebia saya Phase 2 vadadustat study confirmed findings from previous studies »

Akebia Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

07:00
09/26/17
09/26
07:00
09/26/17
07:00
General news
FX Update: The dollar has been in rally mode »

FX Update: The dollar has…

DIS

Disney

$99.57

0.97 (0.98%)

06:59
09/26/17
09/26
06:59
09/26/17
06:59
Periodicals
Disney streams theme-park events in new prototype stores, Bloomberg says »

Walt Disney is opening…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

SPX

S&P 500

06:59
09/26/17
09/26
06:59
09/26/17
06:59
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LCI

Lannett

$17.10

-0.3 (-1.72%)

06:58
09/26/17
09/26
06:58
09/26/17
06:58
Hot Stocks
Lannett revceives approval for Dexmethylphenidate Hydrochloride Tablets »

Lannett announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDX

Market Vector Gold Miners

$23.83

0.36 (1.53%)

06:58
09/26/17
09/26
06:58
09/26/17
06:58
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$124.53

1.29 (1.05%)

06:58
09/26/17
09/26
06:58
09/26/17
06:58
Technical Analysis
SPDR Gold Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXON

Axovant Sciences

$24.25

-0.74 (-2.96%)

06:58
09/26/17
09/26
06:58
09/26/17
06:58
Hot Stocks
Breaking Hot Stocks news story on Axovant Sciences »

Axovant Sciences trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUGT

Direxion Gold Miners Bull

$35.50

1.72 (5.09%)

06:57
09/26/17
09/26
06:57
09/26/17
06:57
Technical Analysis
Direxion Gold Miners Bull: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$20.07

1 (5.24%)

06:57
09/26/17
09/26
06:57
09/26/17
06:57
Technical Analysis
Direxion Daily Jr Gld Mnrs Bull 3X Shrs: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DUST

Direxion Daily Gold Miners Bear 3X ETF

$23.21

-1.2 (-4.92%)

06:57
09/26/17
09/26
06:57
09/26/17
06:57
Technical Analysis
Direxion Daily Gold Miners Bear 3X ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$50.66

-2.87 (-5.36%)

06:56
09/26/17
09/26
06:56
09/26/17
06:56
Technical Analysis
Direxion Daily Junior Gold Miners Index Bear 3x Shares: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VXX

iPath S&P 500 VIX Short-Term Futures

$41.28

0.03 (0.07%)

06:56
09/26/17
09/26
06:56
09/26/17
06:56
Technical Analysis
iPath S&P 500 VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XIV

VelocityShares Daily Inverse VIX Short-Term ETN

$92.69

-0.14 (-0.15%)

06:55
09/26/17
09/26
06:55
09/26/17
06:55
Technical Analysis
VelocityShares Daily Inverse VIX Short-Term ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.